source
- Cyclic peptide drugs gain traction as AI and hybrid synthesis aim to overcome manufacturing hurdlesOral cyclic peptides are attracting attention because they promise the convenience of small‑molecule drugs while delivering antibody‑like selectivity, a combination that is fueling interest after t…
- EMA says regulators pledge API inspection sharing but report modest progressThe European Medicines Agency reports that regulators worldwide are strongly committed to sharing plans for good manufacturing practice inspections of active pharmaceutical ingredient suppliers. D…